home / stock / lly / lly news


LLY News and Press, Eli Lilly and Company From 03/28/24

Stock Information

Company Name: Eli Lilly and Company
Stock Symbol: LLY
Market: NYSE
Website: lilly.com

Menu

LLY LLY Quote LLY Short LLY News LLY Articles LLY Message Board
Get LLY Alerts

News, Short Squeeze, Breakout and More Instantly...

LLY - SPY: Potential, Yes, But Risks Ahead Too

2024-03-28 09:30:13 ET Summary S&P 500 and its replica fund, SPDR S&P 500 ETF Trust, have seen positive performance in Q1 2024, and the potential for the top 10 holdings continues to indicate an upside. However, there are risks to consider when considering investing for re...

LLY - Eli Lilly vs. Berkshire Hathaway: Which Stock Will Become the Next Member of the $1 Trillion Club?

2024-03-28 09:05:00 ET Getting to a $1 trillion market cap is a huge achievement for a company, as only the best of the best can join that club. Not only do companies need to generate strong results, but investors also need to be optimistic about their future growth for their valuations to ...

LLY - Stock-Split Watch: Are These 2 Top Growth Stocks Next?

2024-03-28 08:00:00 ET Are stock splits back in style? About two years ago, a number of high-profile corporations made such moves after their shares rose to unwieldy levels. Now, Chipotle , one of the leading fast-casual restaurant chains, is on the verge of conducting a 50-for-1 stock ...

LLY - Altimmune: Despite HepTcell Failure, Differentiation Of Obesity Drug In Place

2024-03-27 19:50:00 ET Summary Positive results achieved from phase 2 MOMENTUM study, whereby patients not only achieved significant weight loss over a 48-week period with pemvidutide but also had lean mass preservation. It is said that the GLP-1 market could exceed $100 billion b...

LLY - Sen. Sanders goes after Novo Nordisk on study on Ozempic low manufacture cost

2024-03-27 17:02:39 ET More on Novo Nordisk Shaping The Future Of Obesity Treatment: GLP-1 Agonists At The Forefront Novo Nordisk: My 'Hold' Thesis For 2024 - The Premium Must Be Justified Novo Nordisk, A Very Healthy Pharma Stalwart Amazon reportedly leaning...

LLY - Altimmune falls after Q4 results; obesity drug data released

2024-03-27 08:26:15 ET More on Altimmune Altimmune: Taking On Toughest Of Rivals In Obesity - I'm Unconvinced By Recent Rally Altimmune's Pemvidutide Lacks Differentiation In Obesity Treatment Thoroughly Derisked, Altimmune Is Now A Great Buy Altimmune Q4 202...

LLY - XLV: Fundamentals Don't Support Overweighting Health Care

2024-03-27 01:00:24 ET Summary XLV tracks the 64 Health Care stocks in the S&P 500 Index. Its expense ratio is 0.10% and the ETF has over $40 billion in assets under management. With a 12% weighting in the S&P 500 Index, Health Care is already well-represented in most port...

LLY - Amazon reportedly leaning on weight loss frenzy to boost pharmacy unit

2024-03-26 14:15:37 ET More on Amazon, Eli Lilly, etc. Amazon: Still Cheap Even After Robust Rally Amazon Faces Off Against Temu: Who Will Win? Eli Lilly: The Party Is Not Over Amazon making same-day prescription delivery available in NYC and LA Novo ...

LLY - Cytokinetics gains amid renewed takeover speculation

2024-03-26 14:01:03 ET More on Cytokinetics Cytokinetics: CEO Talks Down Buyout Prospects Cytokinetics, Incorporated (CYTK) Q4 2023 Earnings Call Transcript Cytokinetics Steps Up As Prime Target After Aficamten's HCM Triumph (Rating Upgrade) Cytokinetics drif...

LLY - Biotech Roundtable: Is CRISPR all it's cracked up to be?

2024-03-26 11:43:00 ET More on CRISPR Technology Editas Medicine, Inc. (EDIT) Presents at Barclays 26th Annual Global Healthcare Conference (Transcript) Editas Medicine, Inc. (EDIT) Leerink Partners Global Biopharma Conference (Transcript) Editas Medicine, Inc. (EDIT...

Previous 10 Next 10